Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
NAUT Nautilus Biotechnology
2.090+0.030+1.46%
Close
02/03 16:00 ET
2.0900.0000.00%
Post Mkt Price 02/03 16:02 ET
High
2.120
Open
2.050
Turnover
279.01K
Low
2.020
Pre Close
2.060
Volume
134.53K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Head-To-Head Survey: Singular Genomics Systems (NASDAQ:OMIC) and Nautilus Biotechnology (NASDAQ:NAUT)
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform, today announced it will repor
Nautilus Biotechnology Expands to San Diego
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the
Nautilus Biotechnology, Translational Genomics Research Institute Team Up to Advance Study in Childhood Cancer
10:07 AM EST, 01/19/2023 (MT Newswires) -- Nautilus Biotechnology (NAUT) and the Translational Genomics Research Institute said Thursday that they entered into a partnership to study specific protein
Nautilus Biotechnology, TGen Partner to Explore Proteomic Analysis in DIPG
Nautilus Biotechnology Partners With Translational Genomics Research Institute To Investigate Applications Of Single-Molecule Proteomic Analysis In Diffuse Intrinsic Pontine Glioma
Nautilus Biotechnology Partners With Translational Genomics Research Institute To Investigate Applications Of Single-Molecule Proteomic Analysis In Diffuse Intrinsic Pontine Glioma
Contrasting Mettler-Toledo International (NYSE:MTD) and Nautilus Biotechnology (NASDAQ:NAUT)
Mettler-Toledo International (NYSE:MTD – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both computer and technology companies, but which is the superior business? We will comp
Nautilus Biotechnology (NASDAQ:NAUT) Shares Down 10.3%
Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) fell 10.3% during trading on Tuesday . The stock traded as low as $1.55 and last traded at $1.66. 120,820 shares traded hands during mid-day tr
Analyzing Cue Health (NASDAQ:HLTH) and Nautilus Biotechnology (NASDAQ:NAUT)
Cue Health (NASDAQ:HLTH – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 49 companies hit new 52-week lows. Key Facts About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) is the largest company in terms of market cap to set a new 52-week low this morning.The sma
Company Overview
More
ARYA Sciences Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which it refers to as its initial business combination. It has not yet selected any business combination target. The company was founded by Joseph Edelman, Adam Stone, Michael Altman, and Konstantin Poukalov on March 27, 2020 and is headquartered in New York, NY.
CEO： Mr. Sujal M. Patel
Market： NASDAQ
Listing Date： 08/07/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet